BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23032960)

  • 21. [Statins in aortic stenosis].
    Dejanović J; Ivanov I
    Med Pregl; 2009; 62 Suppl 3():101-4. PubMed ID: 19702126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aortic valve replacement reduces valvuloarterial impedance but does not affect systemic arterial compliance in elderly men with degenerative calcific trileaflet aortic valve stenosis.
    Pagel PS; Schroeder AR; De Vry DJ; Hudetz JA
    J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1540-4. PubMed ID: 25267695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of statin on aortic stenosis: a review with meta-analysis.
    Ge H; Zhang Q; Wang BY; He B
    J Clin Pharm Ther; 2010 Aug; 35(4):385-93. PubMed ID: 20831541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valve replacement in aortic stenosis with preoperative mean gradient < 50 mmHg: hemodynamic outcome.
    Blackshear JL; Miller FA; Loutfi H; Finck SJ; Snyder HE; Agnew RC; Orszulak TA
    J Heart Valve Dis; 1996 Nov; 5(6):647-55. PubMed ID: 8953443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do statins slow the progression of aortic valve stenosis?
    Tourmousoglou CE; Lalos S; Psarros T
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):684-9. PubMed ID: 18413348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
    Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of statin treatment on aortic valve and coronary artery calcification.
    Mohler ER; Wang H; Medenilla E; Scott C
    J Heart Valve Dis; 2007 Jul; 16(4):378-86. PubMed ID: 17702362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
    Capoulade R; Clavel MA; Dumesnil JG; Chan KL; Teo KK; Tam JW; Côté N; Mathieu P; Després JP; Pibarot P;
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):165-74. PubMed ID: 23489530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do bisphosphonates slow the progression of aortic stenosis?
    Aksoy O; Cam A; Goel SS; Houghtaling PL; Williams S; Ruiz-Rodriguez E; Menon V; Kapadia SR; Tuzcu EM; Blackstone EH; Griffin BP
    J Am Coll Cardiol; 2012 Apr; 59(16):1452-9. PubMed ID: 22497825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve.
    Kutryb-Zajac B; Jablonska P; Hebanowska A; Lango R; Rogowski J; Slominska EM; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1389-1399. PubMed ID: 32126886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement.
    Pai RG; Kapoor N; Bansal RC; Varadarajan P
    Ann Thorac Surg; 2006 Dec; 82(6):2116-22. PubMed ID: 17126122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg).
    Dichtl W; Alber HF; Feuchtner GM; Hintringer F; Reinthaler M; Bartel T; Süssenbacher A; Grander W; Ulmer H; Pachinger O; Müller S
    Am J Cardiol; 2008 Sep; 102(6):743-8. PubMed ID: 18774000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.
    Wakabayashi K; Tsujino T; Naito Y; Ezumi A; Lee-Kawabata M; Nakao S; Goda A; Sakata Y; Yamamoto K; Daimon T; Masuyama T
    Heart Vessels; 2011 May; 26(3):252-7. PubMed ID: 21063877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMG CoA reductase inhibitor (statin) and aortic valve calcium.
    Shavelle DM; Takasu J; Budoff MJ; Mao S; Zhao XQ; O'Brien KD
    Lancet; 2002 Mar; 359(9312):1125-6. PubMed ID: 11943265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of statins in aortic stenosis. Myth or reality?
    Moura LM; Zamorano J; Peréz-Oteyza C; Rocha-Gonçlves F; Rajamannan NM
    Rev Port Cardiol; 2007 Jan; 26(1):51-62. PubMed ID: 17427836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention.
    Parolari A; Loardi C; Mussoni L; Cavallotti L; Camera M; Biglioli P; Tremoli E; Alamanni F
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):493-504. PubMed ID: 19162497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjusting parameters of aortic valve stenosis severity by body size.
    Minners J; Gohlke-Baerwolf C; Kaufmann BA; Bahlmann E; Gerdts E; Boman K; Chambers JB; Nienaber CA; Willenheimer R; Wachtell K; Holme I; Pedersen TR; Neumann FJ; Jander N
    Heart; 2014 Jul; 100(13):1024-30. PubMed ID: 24780909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside.
    Hermans H; Herijgers P; Holvoet P; Verbeken E; Meuris B; Flameng W; Herregods MC
    Curr Probl Cardiol; 2010 Jun; 35(6):284-306. PubMed ID: 20451759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A medical therapy for aortic valve sclerosis and aortic valve stenosis? Rationale of the ASSIST study (Asymptomatic aortic Sclerosis/Stenosis: Influence of STatins): a large, observational, prospective, multicenter study of the Italian Society of Cardiovascular Echography.
    Antonini-Canterin F; Corrado G; Faggiano P; Popescu BA; Carerj S; La Carrubba S; Zuppiroli A; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2006 Jul; 7(7):464-9. PubMed ID: 16801806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of HMG CoA Reductase Inhibitors on the Progression of Aortic Sclerosis: Review Article.
    Memon S; Ganga HV; Masrur S; Thompson PD
    Conn Med; 2016 Mar; 80(3):169-74. PubMed ID: 27169302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.